Students at Texas A&M University and Texas A&M University-Kingsville will be part of a nationwide study aiming to determine whether young adults who have received the Moderna COVID-19 vaccine can still spread the virus to others.
The COVID-19 Prevention Network, headquartered at the Fred Hutchinson Cancer Research Center in Seattle, announced March 26 the launch of the Prevent COVID U study, which involves students from colleges and universities across the country. Researchers from the Texas A&M University Health Science Center are involved in data collection for the study.
“University students were selected for the study because of high-density housing, zeal to socialize more and less fear of severe disease. These factors are associated with the high burden of SARS-CoV-2 infection on university campuses,” George Udeani, professor at Texas A&M’s College of Pharmacy, said in a university press release.
In total, 12,000 students from 21 universities will participate in the study, and the ages of the participants range from 18 to 26, according to a Tuesday article from the Denver Post.
“This is an incredible opportunity for students of Texas A&M to be part of something big,” Rebecca Fischer, a professor at Texas A&M’s School of Public Health, said in a press release. “The scientific evidence we build will help answer some of the most important questions the world has at this moment about how vaccines work to prevent infections in a real-world scenario. Through this study, we can start answering these questions in the next few months.”